Medikinet Retard Capsule 40 mg (Methylphenidate Hydrochloride)

Adult dose

The dose of this medicine should be individualized according to the patient's response and tolerability. This medicine should be administered with a meal or immediately after a meal. If a patient taking another formulation of methylphenidate hydrochloride is switched to this medicine, it must be administered immediately after a meal. Take this medicine, or its contents, intact with water. Do not chew or crush the contents of this medicine. ○ Adults Administer this medicine 2 times a day (morning and noon), immediately after meals. The initial dose is 5mg per dose, administered 2 times a day (morning and noon). Increase the daily dose by 10mg each week according to the patient's treatment response and tolerability. The maximum daily dose of this medicine is 1mg/kg and must not exceed 80mg a day. Adult patients who have been continuously taking this medicine since childhood or adolescence should continue taking the same dose they are currently taking. 2. Maintenance and long-term treatment The safety and efficacy of this medicine for long-term administration for more than 6 months have not been studied. When prescribing this medicine long term to patients with ADHD, periodically reassess its efficacy for long-term use by temporarily interrupting drug treatment and conducting a trial to evaluate the patient's social functioning. 3. Dose reduction and discontinuation If symptoms worsen or other adverse reactions occur, reduce the dose and, if necessary, discontinue this medicine. If symptoms do not improve within one month after adjustment to an appropriate dose, discontinue this medicine.

Child dose

○ Children and adolescents aged 6 years and older: Administer this medicine once a day, immediately after breakfast. The initial dose is 5mg per dose, administered once a day (in the morning) or 2 times a day (morning and noon). Increase the daily dose by 5 ~ 10mg each week according to the patient's treatment response and tolerability. The maximum daily dose of this medicine is 60mg.

This medication should not be used in children, adolescents, and adults with serious heart problems. Particularly in patients with structural abnormalities or arrhythmias, there is a risk of sudden death, and caution is warranted. In patients with hypertension, blood pressure and pulse should be monitored regularly, and administration should be done with caution. Patients suspected of having heart disease should undergo heart examinations before administration, and if any cardiac-related symptoms arise during treatment, immediate evaluation is required. Patients with psychosis or bipolar disorder may experience worsening symptoms, so caution is necessary. New symptoms of psychosis or mania may develop, and discontinuation of the medication should be considered if these symptoms occur. Aggressiveness or hostility may arise, so behavioral changes should be observed during treatment. If thoughts or behaviors of suicide occur suddenly, medical personnel should be informed immediately, and discontinuation of the medication should be considered if necessary. Long-term use has been reported to suppress growth in children, so careful monitoring of changes in weight and height is necessary. Patients with a history of seizures have a risk of convulsions, so caution should be exercised during administration, and the medication should be discontinued if seizures occur. Visual disturbances may rarely occur, so attention to eye health is also necessary. This medication should not be used in children under 5 years old as safety and efficacy have not been established. Patients with a history of drug dependence or alcohol addiction should be cautious not to adjust the dosage arbitrarily. Persistent painful erections may occur, and if this happens, medical personnel should be informed immediately. Symptoms of peripheral vascular disease may rarely manifest, so changes in hands and feet should be monitored, and additional testing may be needed if necessary. Administration should not occur in patients with severe anxiety, agitation, or excitement, patients with certain ophthalmic conditions, or those taking specific medications. Blood pressure, pulse, weight, height, and mental state should be monitored regularly before and during administration. This medication should be taken with meals, and the capsules can be swallowed whole or sprinkled in applesauce for immediate consumption. Caution is warranted as dizziness may occur while driving or operating machinery. During pregnancy or breastfeeding, careful administration after consulting a physician is necessary, and breastfeeding individuals should consider discontinuing breastfeeding or the medication. In case of overdose, symptoms of excessive central nervous system stimulation may appear, requiring immediate treatment. There may be interactions with other medications, so it is essential to inform healthcare personnel of any medications being taken.

Headache, diarrhea, appendicitis, abdominal pain, loss of appetite, insomnia, nasopharyngitis, restlessness, nausea, palpitations, dizziness, movement disorders, psychomotor hyperactivity, drowsiness, sedation, tremors, seizures, chorea, ischemic neuropathy, neuroleptic syndrome, cerebrovascular disorder, grand mal seizures, migraine, diplopia, blurred vision, visual accommodation disorder, mydriasis, visual impairment, arrhythmia, tachycardia, chest pain, angina, heart murmur, cardiac arrest, myocardial infarction, acute cardiac death, ventricular tachycardia, bradycardia, ventricular extrasystole, ectopic beats, hypertension, cerebral artery occlusion, peripheral coldness, Raynaud's phenomenon, cough, sore throat, shortness of breath, upper abdominal discomfort, vomiting, dry mouth, constipation, elevated liver enzymes, hepatic coma, hair loss, pruritus, rash, urticaria, angioedema, blisters, desquamation, hyperhidrosis, spots, erythema, polymorphous light eruption, exfoliative dermatitis, fixed drug eruption, arthralgia, myalgia, muscle stiffness, muscle spasms, hematuria, irregular menstruation, gynecomastia, fever, growth retardation, fatigue, chest discomfort, abnormal high fever, serotonin syndrome, neuroexcitability, hypersensitivity, fever, arthralgia, necrotizing vasculitis, thrombocytopenic purpura, decreased appetite, abnormal movement disorder, drowsiness, tachycardia, toxic psychosis, hepatic coma, anemia, transient depressive mood, hair thinning, malignant neuroleptic syndrome, suicidal ideation, suicide attempt, hallucinations, delusional thinking, mania, aggression, anxiety, depression, hypersensitivity, abnormal behavior, mental disorder, anger, mood changes, crying, tics, exacerbation of pre-existing tics or Tourette syndrome, hyper-vigilance, sleep disorders, loss of sense of direction, sexual dysfunction, transient depression, abnormal thinking, numbness, repetitive behavior, hyperfocus, confused state, dependence, abuse, persistent painful erection, distal ulcers, soft tissue damage

This medication should be stored in a tightly sealed container to protect it from air or moisture, and it is important to maintain a storage temperature between 1°C and 30°C. Storing it this way ensures the medication's effectiveness and safety.

Appearance

A hard capsule with a dark purple upper part and a gray lower part containing white pellets for immediate release and blue pellets for enteric release.

Package unit

30 capsules (10 capsules/PTP x 3)